Phreesia (PHR) vs Repay (RPAY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Repay (RPAY) has outperformed Phreesia (PHR) over the past year, gaining 21.2% versus a loss of 43.1%. Over five years, RPAY leads with a -77.6% price change compared with -81.0% for PHR. Phreesia is the larger company by market cap ($708.2 million vs $363.9 million), about 1.9 times the size.
On valuation, Repay trades at a lower forward P/E (3.9x vs 7.2x for Phreesia). Phreesia converts more of its revenue into profit, with a net margin of 0.5% versus -83.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PHR | RPAY |
|---|---|---|
| Share price | $11.41 | $3.83 |
| Market cap | $708.23M | $363.92M |
| 1-day change | -3.88% | -4.49% |
| YTD return | -32.57% | +4.93% |
| 1-year return | -43.09% | +21.20% |
| 5-year return | -80.97% | -77.62% |
| P/E ratio (TTM) | 67.12 | — |
| Forward P/E | 7.23 | 3.88 |
| EPS (TTM) | $0.17 | $-2.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $480.59M | $309.26M |
| Revenue growth (YoY) | +14.48% | -1.21% |
| Net income (latest FY) | $2.31M | $-256.72M |
| Gross margin | 85.15% | 75.02% |
| Operating margin | -1.38% | -82.36% |
| Net margin | 0.48% | -83.01% |
| 52-week high | $21.24 | $4.81 |
| 52-week low | $7.77 | $2.30 |
| Distance from 52-week high | -46.28% | -20.29% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +21.56% | +68.67% |
| Average volume | 686.47K | 439.34K |
| Shares outstanding | 62.07M | 89.73M |
| Employees | 1,789 | 486 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Business Services | Business Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RPAY has outperformed PHR by 64.3 percentage points over the past year.
- Phreesia is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -83.0 cents for Repay.
- Phreesia grew revenue faster in its latest fiscal year (+14.48% vs -1.21%).
About Phreesia
PHR stock →Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
Consumer Discretionary · Business Services · 1,789 employees
About Repay
RPAY stock →Repay Holdings Corporation, a payments technology company, provides integrated payment processing solutions that enables consumers and businesses to make payments using electronic payment methods in the United States. It operates through two segments: Consumer Payments and Business Payments.
Consumer Discretionary · Business Services · 486 employees
PHR vs RPAY FAQ
Which is bigger, Phreesia or Repay?
Phreesia (PHR) is larger, with a market capitalization of $708.23M compared with $363.92M for Repay (RPAY).
Which stock has performed better over the past year, PHR or RPAY?
RPAY returned +21.20% over the past 12 months, compared with -43.09% for PHR (price return, excluding dividends). Past performance does not predict future results.
Are Phreesia and Repay in the same industry?
Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.